Imperva (NASDAQ:IMPV) was upgraded by equities researchers at Piper Jaffray Companies from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Friday, MarketBeat reports. The firm currently has a $52.00 price objective on the software maker’s stock. Piper Jaffray Companies’ target price would suggest a potential upside of 11.71% from the stock’s previous close.
IMPV has been the subject of a number of other research reports. BidaskClub lowered shares of Imperva from a “hold” rating to a “sell” rating in a research report on Wednesday, December 27th. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price for the company in a research report on Tuesday, October 24th. Morgan Stanley reiterated an “underweight” rating and issued a $39.00 target price on shares of Imperva in a research report on Thursday, November 9th. Stifel Nicolaus reiterated a “hold” rating and issued a $47.00 target price (down previously from $50.00) on shares of Imperva in a research report on Thursday, November 9th. Finally, Evercore ISI set a $56.00 target price on shares of Imperva and gave the company a “buy” rating in a research report on Thursday, October 19th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $52.93.
Imperva (NASDAQ IMPV) traded up $4.50 during trading on Friday, hitting $46.55. 2,138,319 shares of the stock traded hands, compared to its average volume of 271,353. The company has a market capitalization of $1,430.29, a price-to-earnings ratio of 68.46 and a beta of 1.79. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $52.40.
Large investors have recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in shares of Imperva during the 3rd quarter valued at about $134,000. First Quadrant L P CA bought a new position in shares of Imperva during the 3rd quarter valued at about $136,000. Ameritas Investment Partners Inc. boosted its position in shares of Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares in the last quarter. Amalgamated Bank bought a new position in shares of Imperva during the 2nd quarter valued at about $206,000. Finally, Principal Financial Group Inc. bought a new position in shares of Imperva during the 2nd quarter valued at about $223,000. Institutional investors own 96.61% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.